Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Daiichi Sankyo
Daiichi Sankyo
Lilly heart drug Effient fails to carve new niche
Reuters
Sun, 08/26/12 - 11:04 am
Eli Lilly
Effient
Plavix
Daiichi Sankyo
Sanofi
antiplatelet therapy
Bristol-Myers Squibb
TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients
Forbes
Sun, 08/26/12 - 11:02 am
Sanofi
Prasugrel
Plavix
Effient
Daiichi Sankyo
Clopidogrel
antiplatelet therapy
Eli Lilly
China Biotech In Review: Fidelity Starts New VC Fund For China Healthcare
Seeking Alpha
Sun, 04/22/12 - 01:28 pm
Fidelity Investments
Daiichi Sankyo
Shanghai Xinshengyuan
Luqa Pharma
Ebernet
Cyclacel: An Intriguing Long Shot
Seeking Alpha
Tue, 03/20/12 - 10:35 am
Cyclacel
Sapacitabine
cancer
Daiichi Sankyo
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Seattle Genetics
Celldex
Arqule
Daiichi Sankyo
JNJ
Medivation
Dendreon
Aveo Pharmaceutical
Ariad Pharmaceuticals
AstraZeneca
Array Biopharma
Oncothyreon
Daiichi Sankyo, GlaxoSmithKline Form Vaccine Venture
WSJ Online
Mon, 03/5/12 - 11:03 am
GSK
vaccines
Daiichi Sankyo
Japan
ArQule license deal with Daiichi could land $265M
Bizjournals.com
Thu, 11/10/11 - 01:09 pm
Arqule
Daiichi Sankyo
kinase inhibitors
Daiichi Sankyo Cuts Full-Year Sales Forecast on Stronger Yen
Bloomberg
Mon, 10/31/11 - 12:00 pm
earnings
Daiichi Sankyo
Daiichi Unit Warned By FDA Over Manufacturing
Pharmalot
Wed, 09/14/11 - 11:14 am
FDA
warnings
Daiichi Sankyo
Luitpold
drug manufacturing
Roche, Daiichi Sankyo Win U.S. Approval on Drug to Treat Advanced Melanoma
Bloomberg
Wed, 08/17/11 - 12:03 pm
Zelboraf
Roche
melanoma
FDA
Daiichi Sankyo
Melanoma Set to Be a Hot Topic at ASCO
WSJ Online
Wed, 06/1/11 - 12:35 pm
ASCO
melanoma
skin cancer
Yervoy
Bristol-Myers Squibb
Daiichi Sankyo
Roche
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Bloomberg
Wed, 05/25/11 - 09:28 am
Roche
skin cancer
melanoma
vemurafenib
GSK
Bristol-Myers Squibb
Daiichi Sankyo
Yervoy
Ranbaxy Falls Most in 6 Weeks After $1 Billion Fines Report
Bloomberg
Thu, 05/5/11 - 07:31 am
Ranbaxy
India
Daiichi Sankyo
Watson confirms Welchol patent challenge
pharmabiz
Sat, 04/23/11 - 11:13 am
Watson Pharmaceuticals
Welchol
Daiichi Sankyo
Genzyme
Genomics companies finally bear fruit
Fierce Biotech
Fri, 03/18/11 - 10:24 am
genomics
Daiichi Sankyo
Illumina
Life Technologies
Pacific Biosciences
Daiichi Yet to Gain from Ranbaxy Buy
WSJ Online
Tue, 03/15/11 - 09:07 am
Daiichi Sankyo
Ranbaxy
Daiichi Sankyo, Kyowa Hakko Signal More Japanese Drug Takeovers
Bloomberg
Wed, 03/2/11 - 10:33 am
Japan
Kyowa Hakko Kirin
Daiichi Sankyo
Plexxikon
Prostrakan
M&A
Daiichi Sankyo nabs tiny Plexxikon in $935M deal
Fierce Biotech
Tue, 03/1/11 - 07:57 am
Plexxikon
Daiichi Sankyo
M&A
Daiichi Sankyo Profit Grows 34%
WSJ
Mon, 01/31/11 - 08:13 am
Daiichi Sankyo
earnings
Daiichi Sankyo US unit buys Roxro Pharma to gain pain drug SPRIX
The Pharma Letter
Tue, 12/14/10 - 11:03 am
Roxro
M&A
Daiichi Sankyo
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
next ›
last »